Author

C. Tarantelli

Observed names: Chiara Tarantelli, Tarantelli C

Observed institution: Institute of Oncology Research

OpenAlex ID: A5081021683

The novel mTORC1/2 inhibitor PQR620 has in vitro and in vivo activity in lymphomas

2016 · C. Tarantelli, E. Gaudio, et al. · European Journal of Cancer · 1

33 (PB021): Loss-of-function and gain-of-function genetic screens identify potential biomarkers and combination partners for the highly selective allosteric PI3Kδ inhibitor roginolisib (IOA-244)

2024 · C. Tarantelli, G. Sartori, et al. · European Journal of Cancer

Abstract 552: Multi-scale omics integration using parallel heatmap clustering for the systemic analysis and biomarker discovery of drug sensitivity in lymphoma cell lines

2017 · Ivo Kwee, Andrea Rinaldi, et al. · Cancer Research

The BET bromodomain inhibitor (BET-i) BAY 1238097: Mechanism of action and pre-clinical activity in diffuse large B-cell lymphoma (DLBCL)

2016 · E. Bernasconi, E. Gaudio, et al. · European Journal of Cancer

568 The BET bromodomain inhibitor OTX015 shows synergy with several anticancer agents in preclinical models of mantle cell lymphoma (MCL) and multiple myeloma (MM)

2014 · E. Bernasconi, C. Tarantelli, et al. · European Journal of Cancer

Works count: 6

Citation count: 1

H-index: 1

I10-index: